| Previous close | 7.59 |
| Open | 6.41 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 1,020.00 |
| Expiry date | 2024-08-16 |
| Day's range | 6.35 - 7.80 |
| Contract range | N/A |
| Volume | |
| Open interest | 43 |
- Yahoo Finance Video
FDA panel votes to recommend Eli Lilly's Alzheimer's drug
A US Food and Drug Administration (FDA) panel voted unanimously 11-0 to recommend the approval of Eli Lilly's (LLY) Alzheimer's drug, donanemab. Yahoo Finance's Anjalee Khemlani reports more on the story and the drug's ability to slow cognitive decline. Read more about donanemab here. For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Melanie Riehl
Barrons.comThese Stocks Are Moving the Most Today: Apple, GM, Yext, Eli Lilly, Calavo Growers, Oracle, and More
Apple shares trade lower after the tech giant unveils its long-awaited approach to generative artificial intelligence, GM’s board authorizes a new $6 billion buyback plan, and Yext tumbles after reporting a wider first-quarter loss. Oracle, meanwhile, is scheduled to report quarterly earnings after the closing bell Tuesday.
Yahoo Finance UKTrending tickers: Apple, Lily, AMD and FirstGroup
The latest investor updates on stocks that are trending on Tuesday
